Abundant TRAF1 expression is a hallmark of multiple EBV-associated human malignancies, including Hodgkin lymphoma and post-transplant lymphoproliferative disorder [47,48,49]. This evidence concerns the gene TRAF1 and lymphoproliferative syndrome.